Phase I clinical trial of recombinant human interleukin-3 combined with carboplatin in the treatment of patients with recurrent ovarian carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/8487328

J. Natl. Cancer Inst. 1993 May 19 85 10 823-5

Download in:

View as

General Info

PMID
8487328